Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial

South Africa News News

Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial
South Africa South Africa Latest News,South Africa South Africa Headlines

The company said the decision to end the trial was not based on safety concerns

  • 📰 The Independent
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 59%

Biogen, one of the largest biotechs in the world, said the decision to stop the study was not based on safety concerns.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

The Independent /  🏆 80. in ZA
 

South Africa South Africa Latest News, South Africa South Africa Headlines



Render Time: 2025-01-14 02:47:29